These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 20308643

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Trends in socioeconomic status-related differences in mortality among people with chronic obstructive pulmonary disease.
    Gershon AS, Hwee J, Victor JC, Wilton AS, To T.
    Ann Am Thorac Soc; 2014 Oct; 11(8):1195-202. PubMed ID: 25166428
    [Abstract] [Full Text] [Related]

  • 5. Trends in COPD mortality and hospitalizations in countries and regions of Asia-Pacific.
    Tan WC, Seale P, Ip M, Shim YS, Chiang CH, Ng TP, Abisheganadan J, Charoenratanakul S, DeGuia T, Mahayiddin A, Mangunnegoro H, Xu YJ, Zhong NS.
    Respirology; 2009 Jan; 14(1):90-7. PubMed ID: 19144054
    [Abstract] [Full Text] [Related]

  • 6. Mortality trends in women and men with COPD in Ontario, Canada, 1996-2012.
    Gershon A, Hwee J, Victor JC, Wilton A, Wu R, Day A, To T.
    Thorax; 2015 Feb; 70(2):121-6. PubMed ID: 25428609
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
    Gershon AS, Wang L, To T, Luo J, Upshur RE.
    COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148
    [Abstract] [Full Text] [Related]

  • 9. [The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study].
    Geldmacher H, Biller H, Herbst A, Urbanski K, Allison M, Buist AS, Hohlfeld JM, Welte T.
    Dtsch Med Wochenschr; 2008 Dec; 133(50):2609-14. PubMed ID: 19052996
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey.
    Zhong N, Wang C, Yao W, Chen P, Kang J, Huang S, Chen B, Wang C, Ni D, Zhou Y, Liu S, Wang X, Wang D, Lu J, Zheng J, Ran P.
    Am J Respir Crit Care Med; 2007 Oct 15; 176(8):753-60. PubMed ID: 17575095
    [Abstract] [Full Text] [Related]

  • 15. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM, Akazawa M, Dalal A, Simoni-Wastila L.
    Am J Geriatr Pharmacother; 2008 Aug 15; 6(3):138-46. PubMed ID: 18775388
    [Abstract] [Full Text] [Related]

  • 16. The silent epidemic among Wisconsin women: chronic obstructive pulmonary disease trends, 1980-2000.
    Edwards NM, Umland M, Ahrens D, Remington P.
    WMJ; 2005 May 15; 104(4):50-4. PubMed ID: 16117235
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Increasing incidence and prevalence with limited survival gains among rural Albertans with diabetes: a retrospective cohort study, 1995-2006.
    Johnson JA, Balko SU, Hugel G, Low C, Svenson LW.
    Diabet Med; 2009 Oct 15; 26(10):989-95. PubMed ID: 19900230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.